Abstract
Correct myelination is crucial for the function of the peripheral nervous system. Both positive and negative regulators within the axon and Schwann cell function to ensure the correct onset and progression of myelination during both development and following peripheral nerve injury and repair. The Sox2 transcription factor is well known for its roles in the development andmaintenance of progenitor and stem cell populations, but has also been proposed in vitro as a negative regulator of myelination in Schwann cells. We wished to test fully whether Sox2 regulates myelination in vivo and show here that, in mice, sustained Sox2 expression in vivo blocks myelination in the peripheral nerves and maintains Schwann cells in a proliferative non-differentiated state, which is also associated with increased inflammation within the nerve. The plasticity of Schwann cells allows them to re-myelinate regenerated axons following injury and we show that re-myelination is also blocked by Sox2 expression in Schwann cells. These findings identify Sox2 as a physiological regulator of Schwann cell myelination in vivo and its potential to play a role in disorders of myelination in the peripheral nervous system.
Original language | English |
---|---|
Pages (from-to) | 3114-3125 |
Number of pages | 12 |
Journal | Development |
Volume | 144 |
Issue number | 17 |
Early online date | 29 Aug 2017 |
DOIs | |
Publication status | Published - 1 Sept 2017 |
Keywords
- Mouse
- Myelination
- Peripheral nervous system
- Repair
- Schwann cell
- Sox2
ASJC Scopus subject areas
- Molecular Biology
- Developmental Biology